“Highly unusual and unfortunate error” delays retraction two years in high-profile Duke case

As we’ve noted before, “the wheels of scientific publishing turn slowly … but they do (sometimes) turn.”  More than six years after the first retraction for Erin Potts-Kant, who was part of a group at Duke whose work would unravel amid misconduct allegations and lead to a $112.5 million settlement earlier this year with the … Continue reading “Highly unusual and unfortunate error” delays retraction two years in high-profile Duke case

Weekend reads: The scale of misconduct in China; toxic peer reviews; license to publish?; an editorial revolt

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured a researcher at Northwestern who’s up to five retractions; a … Continue reading Weekend reads: The scale of misconduct in China; toxic peer reviews; license to publish?; an editorial revolt

Weekend reads: PhD sues alma mater for alleged retaliation; an unexpected rejection; saying no to peer review requests

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured a former postdoc who faked nearly 60 experiments; an apology … Continue reading Weekend reads: PhD sues alma mater for alleged retaliation; an unexpected rejection; saying no to peer review requests

“I sincerely apologise:” UK cancer researcher calls for retraction of his work years after it’s flagged on PubPeer

A cancer researcher in England says he will be retracting a 2011 paper after acknowledging “unacceptable” manipulation of some of the figures in the article. Richard Hill, of the University of Portsmouth, this week agreed to retract the article, “DNA-PKcs binding to p53 on the p21WAF1/CIP1 promoter blocks transcription resulting in cell death,” which appeared … Continue reading “I sincerely apologise:” UK cancer researcher calls for retraction of his work years after it’s flagged on PubPeer

Weekend reads: Self-citation farms; an editor refuses to retract; publishing enters politics

Before we present this week’s Weekend Reads, a request: Our co-founder Ivan Oransky celebrated a birthday this past week, and he’d like nothing more than a gift to Retraction Watch to support our work. Here’s your chance. The week at Retraction Watch featured a massive correction for a paper used to support the ban on Caster … Continue reading Weekend reads: Self-citation farms; an editor refuses to retract; publishing enters politics

Weekend reads: A week of whistleblower news, including what happens when one gets it wrong; questions about a widely covered study of men with guitar bags

Before we present this week’s Weekend Reads, a request: Our co-founder Ivan Oransky is celebrating a birthday this coming week, and he’d like nothing more than a gift to Retraction Watch to support our work. Here’s your chance. The week at Retraction Watch featured a psychology researcher who did the right thing; 15 retractions by … Continue reading Weekend reads: A week of whistleblower news, including what happens when one gets it wrong; questions about a widely covered study of men with guitar bags

Retraction Watch readers, we still need your help to be able to continue our work

Dear Retraction Watch readers: Maybe you’re a researcher who likes keeping up with developments in scientific integrity. Maybe you’re a reporter who has found a story idea on the blog. Maybe you’re an ethics instructor who uses the site to find case studies. Or a publisher who uses our blog to screen authors who submit … Continue reading Retraction Watch readers, we still need your help to be able to continue our work

Journals retract more than a dozen studies from China that may have used executed prisoners’ organs

In the past month, PLOS ONE and Transplantation have retracted fifteen studies by authors in China because of suspicions that the authors may have used organs from executed prisoners. All of the original studies — seven in Transplantation, and eight in PLOS ONE — were published between 2008 and 2014. Two involved kidney transplants, and … Continue reading Journals retract more than a dozen studies from China that may have used executed prisoners’ organs

Weekend reads: The dark side of tenure; video game-gun violence retractions; data fraud in the drug industry

Before we present this week’s Weekend Reads, a question: Do you enjoy our weekly roundup? If so, we could really use your help. Would you consider a tax-deductible donation to support Weekend Reads, and our daily work? Thanks in advance. The week at Retraction Watch featured us wondering why it takes a publisher a year and … Continue reading Weekend reads: The dark side of tenure; video game-gun violence retractions; data fraud in the drug industry

Conflicts of disinterest: Why does it take a publisher 18 months, and counting, to correct papers?

On February 23, 2018, Stephen Barrett — a physician in the United States perhaps best known for his work at Quackwatch — sent Dove Press this message: I believe you have published 20 articles in 6 of your journals in which the lead author did not make a full conflict-of-interest disclosure. Please email me directly … Continue reading Conflicts of disinterest: Why does it take a publisher 18 months, and counting, to correct papers?